SL
NMRD

Salomon & Ludwin’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Salomon & Ludwin’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$1 – 893
2023
Q4 		$1 Hold
3
– – ﹤0.01% 762
2023
Q3 		$1 Buy
+3
New +$2 ﹤0.01% 759

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Salomon & Ludwin's NMRD Position: Q1 2024 in Review

Salomon & Ludwin sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 3 shares — an estimated $1 sold.

Salomon & Ludwin first reported a position in NMRD in Q3 2023 and held it in 2 quarters. The position peaked at $1 in Q4 2023. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Salomon & Ludwin reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Salomon & Ludwin sold 3 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $1.
  • Salomon & Ludwin first reported a position in Nemaura Medical, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Salomon & Ludwin's Nemaura Medical, Inc. Common Stock position peaked at $1 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Salomon & Ludwin's 13F filing for Q1 2024, filed 2 May 2024.